Michel Rivoire Selected Research

Michel Rivoire Research Topics

Disease

23	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2002
18	Neoplasms (Cancer) 10/2023 - 02/2006
14	Infections 05/2024 - 11/2015
8	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 12/2002
5	Rectal Neoplasms (Rectal Cancer) 01/2020 - 02/2006
5	Melanoma (Melanoma, Malignant) 01/2020 - 06/2005
4	Carcinoma (Carcinomatosis) 01/2021 - 04/2013
3	Uveal melanoma 05/2024 - 06/2005
3	Residual Neoplasm 01/2020 - 05/2008
3	Liver Diseases (Liver Disease) 07/2019 - 07/2012
2	Chronic Hepatitis B 05/2024 - 01/2018
2	Liver Failure 11/2023 - 12/2012
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021 - 06/2010
2	Hepatocellular Carcinoma (Hepatoma) 11/2020 - 01/2018
2	Hemorrhage 07/2012 - 01/2006
1	Thrombosis (Thrombus) 03/2024
1	Retroperitoneal Neoplasms 03/2024
1	Pelvic Neoplasms 10/2023
1	Reinfection 01/2023
1	Human Viral Hepatitis 01/2023
1	Coinfection 01/2023
1	Superinfection 01/2023
1	Inflammation (Inflammations) 11/2022
1	Microsatellite Instability 04/2022
1	Hepatitis B 10/2021
1	Persistent Infection 11/2020
1	Stomach Neoplasms (Stomach Cancer) 10/2019
1	Lymphadenopathy 07/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2019
1	Circulating Neoplastic Cells 01/2019
1	Postoperative Pain 01/2019
1	Wounds and Injuries (Trauma) 01/2019
1	Margins of Excision 01/2017

Drug/Important Bio-Agent (IBA)

4	RNA (Ribonucleic Acid)IBA 05/2024 - 01/2022
3	Peptides (Polypeptides)IBA 01/2023 - 01/2022
3	Bevacizumab (Avastin)FDA Link 01/2022 - 12/2012
3	Cetuximab (Erbitux)FDA Link 01/2022 - 01/2016
2	Taurocholic Acid (Sodium Taurocholate)IBA 01/2023 - 01/2022
2	Hepatitis delta Antigens (HDAg)IBA 01/2023 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2014
2	InterferonsIBA 01/2023 - 03/2022
2	Netrin-1IBA 11/2022 - 01/2018
2	folfirinoxIBA 01/2022 - 12/2013
2	Antiviral Agents (Antivirals)IBA 01/2022 - 11/2015
2	Viral DNAIBA 01/2022 - 10/2021
2	CytokinesIBA 12/2019 - 01/2016
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2016 - 06/2010
1	Melphalan (Alkeran)FDA LinkGeneric 05/2024
1	selgantolimodIBA 05/2024
1	Conditioned Culture MediaIBA 05/2024
1	Toll-Like Receptor 8IBA 05/2024
1	diclofenac hydroxyethylpyrrolidine (DIEP)FDA Link 10/2023
1	CalciumIBA 01/2023
1	Lysosomal-Associated Membrane Protein 1IBA 01/2023
1	Green Fluorescent ProteinsIBA 01/2023
1	GW 4064IBA 01/2023
1	LigandsIBA 01/2023
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2023
1	bafilomycin A1IBA 01/2023
1	Immune Checkpoint InhibitorsIBA 04/2022
1	Investigational DrugsIBA 03/2022
1	ChromatinIBA 01/2022
1	Histones (Histone)IBA 01/2022
1	Staphylococcal Protein A (Protein A)IBA 10/2021
1	VaccinesIBA 11/2020
1	Cell-Free Nucleic AcidsIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	pgRNAIBA 01/2020
1	Local AnestheticsIBA 01/2019
1	Morphine (MS Contin)FDA LinkGeneric 01/2019
1	Analgesics (Analgesic Drugs)IBA 01/2019
1	Ropivacaine (Naropin)FDA LinkGeneric 01/2019
1	Circulating Tumor DNAIBA 01/2019
1	Interleukin-18 (Interleukin 18)IBA 01/2016
1	InflammasomesIBA 01/2016
1	Fluorouracil (Carac)FDA LinkGeneric 01/2016
1	Leucovorin (Folinic Acid)FDA Link 01/2016
1	NucleosidesIBA 01/2016
1	Interleukin-8 (Interleukin 8)IBA 01/2016
1	Dihydrotachysterol (AT 10)IBA 03/2015

Therapy/Procedure

13	Drug Therapy (Chemotherapy) 01/2022 - 12/2002
11	Hepatectomy 11/2023 - 01/2006
11	Therapeutics 01/2023 - 04/2013
4	Chemoradiotherapy 01/2020 - 04/2013
4	Cytoreduction Surgical Procedures 10/2019 - 10/2005
3	Proton Therapy 01/2020 - 06/2005
2	Hyperthermic Intraperitoneal Chemotherapy 10/2019 - 12/2012
2	Neoadjuvant Therapy 01/2017 - 12/2002
2	Lymph Node Excision (Lymph Node Dissection) 01/2015 - 02/2012
1	Prostheses and Implants (Prosthesis) 03/2024
1	Laparotomy 10/2023
1	Pelvic Exenteration 06/2023
1	Precision Medicine 01/2022
1	Proctectomy 01/2021
1	Combined Modality Therapy 01/2020
1	Surgical Instruments (Clip) 01/2017
1	Blood Transfusion (Blood Transfusions) 01/2017
1	Length of Stay 01/2017
1	Induction Chemotherapy 01/2016
1	Brachytherapy 03/2015